We have extensive experience of appraising and valuing IP assets in the Pharma & Life Sciences sector.
Our Client Results explain why businesses in your sector are relying on our diligence-led, IP valuations to support M&A, exit, fundraising & investment
Pharma & Life Sciences Recent Featured Engagements